RHYTHM PHARMACEUTICALS, INC. (16)

Browse by Contract Category

Contracts

Asset Purchase Agreement, dated as of January 5, 2021, by and between Rhythm Pharmaceuticals, Inc. and Alexion Pharmaceuticals, Inc (Filed With SEC on January 5, 2021)
Separation Agreement, dated September 30, 2020, between Rhythm Pharmaceuticals, Inc. and Nithya Desikan (Filed With SEC on November 2, 2020)
Amendment No. 2 to Development and Manufacturing and Services Agreement, dated as of July 15, 2020, by and between the Company and Corden Pharma Brussels S.A (Filed With SEC on August 3, 2020)
Offer Letter, dated July 16, 2020, between Rhythm Pharmaceuticals, Inc. and David P. Meeker, M.D (Filed With SEC on July 21, 2020)
First Amendment to Lease, dated April 15, 2016 (Filed With SEC on March 8, 2019)
Offer Letter, dated September 4, 2020, and Indefinite Term Employment Contract, dated October 5, 2020, between Rhythm Pharmaceuticals, Inc. and Yann Mazabraud (Filed With SEC on November 2, 2020)
Summary of Non-Employee Director Compensation Policy (Filed With SEC on May 4, 2020)
Offer Letter, dated December 21, 2017, by and between the Company and Hunter C. Smith (Filed With SEC on May 4, 2020)
Amendment No. 1 to Development and Manufacturing and Services Agreement, dated as of February 20, 2020, by and between the Company and Corden Pharma Brussels S.A (Filed With SEC on May 4, 2020)
Description of the Registrants Securities registered pursuant to Section 12 of the Securities Exchange Act of 1934 (Filed With SEC on March 2, 2020)
Form of Restricted Stock Unit Award Agreement (Filed With SEC on March 2, 2020)
Separation Agreement and General Release dated January 6, 2020 (Filed With SEC on January 8, 2020)
Consulting Agreement dated January 6, 2020 (Filed With SEC on January 8, 2020)
Underwriting Agreement dated October 15, 2019 (Filed With SEC on October 16, 2019)
Summary of Non-Employee Director Compensation Policy (Filed With SEC on July 25, 2019)
Offer Letter, dated September 13, 2017, by and between the Registrant and Lex H.T. Van der Ploeg (Filed With SEC on March 8, 2019)